glp-1 microdosing chart Tirzepatide and Semaglutide for Weight Loss Tapering off of or Microdosing

Research subjects report that the metallic aftertaste persists for 2040 minutes after sublingual administration, even after rinsing with water or consuming flavored beverages

Cardiovascular Safety : The cardiovascular safety of tirzepatide has been evaluated and confirmed to date through a pre-specified meta-analysis of phase 2 and 3 randomized trials comparing tirzepatide with other placebo, insulin glargine, degludec, semaglutide, dulaglutide for a minimum of 26 weeks (including the GPGB, SURPASS 1,2,3,4,5, and J-mono studies) [67]

B.ChristodoulouE.et al

Based on previous data, lowering plasma TMAO levels may reduce adverse outcomes of CVD

Lancet 2018;392:151929.PubMed 70